PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C

Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores

(2016) Ragesh B. Thandassery et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

(2016) Jun L. Chin et al.   Frontiers in Pharmacology

The Feasibility and Reliability of Transient Elastography Using Fibroscan®: A Practice Audit of 2335 Examinations

(2016) Jack XQ Pang et al.   Canadian Journal of Gastroenterology and Hepatology

The PAPAS index

(2015) Banu D. Ozel et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients

(2015) Mette J. Nielsen et al.   PLoS One

Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar

(2014) M. A. Karsdal et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C

(2014) Mette J. Nielsen et al.   LIVER INTERNATIONAL

PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension

(2014) Christian Jansen et al.   PLoS One

Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis-a serological evaluation

(2012) Diana J. Leeming et al.   LIVER INTERNATIONAL

Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients

(2011) Krista J. M. Stibbe et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

(2009) Nikolai Mühlberger et al.   BMC PUBLIC HEALTH

Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

(2008) Martin Lagging et al.   HEPATOLOGY